Smart interfaces to assist the operator in the context of industry 4.0 with a 5S human-centric approach.

This paper explores the integration of haptic gloves and virtual reality (VR) environments to enhance industrial training and operational efficiency within the framework of Industry 4.0 and Industry 5.0.

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Background: Glioblastoma (GBM) has a median survival of <2 years. Pexidartinib (PLX3397) is a small-molecule inhibitor of CSF1R, KIT, and oncogenic FTL3, which are implicated in GBM treatment resistance. Results from glioma models indicate that combining radiation therapy (RT) and pexidartinib reduces radiation resistance.

A static rooftop shading system for year-round thermal comfort and energy savings in hot climates.

In sun-drenched regions, balancing solar exposure for thermal comfort and minimization of cooling energy presents a key challenge. While passive shading mitigates summer heat gain, it also hinders winter solar benefits, a problem that is echoed by active systems such as photovoltaic panels. Existing adaptive solutions, adjusting to seasonal sun angles, offer flexibility, but introduce complexity, maintenance demands, and potentially higher costs.

[Sclerosing pneumocytoma: an old disease with a rare presentation].

Pulmonary pneumocytoma, formerly known as sclerosing hemangioma, is a rare, benign tumor that frequently affects women in the 4th and 5th decades of life. Here we present the case of a 17-year-old patient with a diagnosis of sclerosing pneumocytoma with infrequent presentation.

PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth.

Thyroid carcinoma (TC) is the most common endocrine neoplasia, with its incidence increasing in the last 40 years worldwide. The determination of genetic and/or protein markers for thyroid carcinoma could increase diagnostic precision. Accumulated evidence shows that Protein kinase C alpha (PKCα) contributes to tumorigenesis and therapy resistance in cancer.